Anebulo Pharmaceuticals (ANEB) Change in Accured Expenses (2020 - 2025)
Anebulo Pharmaceuticals (ANEB) posted Change in Accured Expenses of $574,502 for fiscal Q2 2026 (quarter ended Dec 31, 2025), up 137.2% from $242,201 a year earlier and up 519.3% from the prior quarter.
Powered by 
Analysis
Anebulo Pharmaceuticals (ANEB) Change in Accured Expenses (2020 - 2025) Analysis & Trends
For the trailing twelve months through Dec 31, 2025, Change in Accured Expenses at Anebulo Pharmaceuticals was $371,500; for FY2025 (ended Jun 30, 2025), it came in at $159,356.
- Annual Change in Accured Expenses shows a five-year compound annual growth rate of 47.8% (FY2020 to FY2025).
- In prior fiscal years, Anebulo Pharmaceuticals' Change in Accured Expenses was -$430,099 in FY2024, $402,553 in FY2023, $118.00 in FY2022 (-99.9%) and $109,006 in FY2021 (+382.8%).
- The fiscal Q2 2026 figure stands as the highest quarterly Change in Accured Expenses since fiscal Q2 2023.
- According to Business Quant data, Change in Accured Expenses for the three prior fiscal quarters was $92,769 (Q1 2026), $145,059 (Q4 2025) and -$440,830 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 2.96 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -251.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 901.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 338.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Anebulo Pharmaceuticals | 13.15 Mn | 13.15 Mn | - | 574,502.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 574,502.00 |
| Sep 30, 2025 | 92,769.00 |
| Jun 30, 2025 | 145,059.00 |
| Mar 31, 2025 | -440,830.00 |
| Dec 31, 2024 | 242,201.00 |
| Sep 30, 2024 | 212,926.00 |
| Jun 30, 2024 | -521,244.00 |
| Mar 31, 2024 | -69,476.00 |
| Dec 31, 2023 | 544,266.00 |
| Sep 30, 2023 | -383,645.00 |
| Jun 30, 2023 | -385,927.00 |
| Mar 31, 2023 | -105,664.00 |
| Dec 31, 2022 | 851,141.00 |
| Sep 30, 2022 | 43,003.00 |
| Jun 30, 2022 | 129,203.00 |
| Mar 31, 2022 | -4,500.00 |
| Dec 31, 2021 | -106,887.00 |
| Sep 30, 2021 | -17,698.00 |
| Jun 30, 2021 | -79,554.00 |
| Mar 31, 2021 | 151,193.00 |
API Access
Anebulo Pharmaceuticals Change in Accured Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=ANEB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "ANEB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=ANEB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();